Consolidated Statements of Income (USD $)	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
REVENUES:
Patient revenues, net	$ 314,715,000	$ 290,130,000	$ 276,979,000
EXPENSES:
Operating	243,929,000	229,081,000	219,567,000
Lease	22,939,000	22,600,000	21,791,000
Professional liability	10,962,000	5,364,000	8,228,000
General and administrative	25,589,000	19,680,000	17,926,000
Depreciation and amortization	6,592,000	5,825,000	5,446,000
Asset impairment	344,000
Total expenses	310,355,000	282,550,000	272,958,000
OPERATING INCOME	4,360,000	7,580,000	4,021,000
OTHER INCOME (EXPENSE):
Foreign currency transaction gain			191,000
Other income			549,000
Interest income	11,000	2,000	161,000
Interest expense	(2,366,000)	(1,634,000)	(1,877,000)
Debt retirement costs	(112,000)	(127,000)
Total other income (expense)	(2,467,000)	(1,759,000)	(976,000)
INCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	1,893,000	5,821,000	3,045,000
PROVISION FOR INCOME TAXES	(509,000)	(1,858,000)	(1,165,000)
NET INCOME FROM CONTINUING OPERATIONS	1,384,000	3,963,000	1,880,000
NET INCOME FROM DISCONTINUED OPERATIONS:
Operating income (loss), net of tax (benefit) provision of $(6,000), $177,000 and $449,000, respectively	(17,000)	344,000	721,000
Disposal and impairment, net of tax benefit of $217,000		(458,000)
DISCONTINUED OPERATIONS	(17,000)	(114,000)	721,000
NET INCOME	1,367,000	3,849,000	2,601,000
Preferred stock dividends	(344,000)	(344,000)	(344,000)
NET INCOME FOR COMMON STOCK	$ 1,023,000	$ 3,505,000	$ 2,257,000
Per common share - basic
Continuing operations	$ 0.18	$ 0.63	$ 0.27
Discontinued operations		$ (0.02)	$ 0.13
Total per common share - basic	$ 0.18	$ 0.61	$ 0.40
Per common share - diluted
Continuing operations	$ 0.18	$ 0.62	$ 0.26
Discontinued operations	$ (0.01)	$ (0.02)	$ 0.13
Total per common share - diluted	$ 0.17	$ 0.60	$ 0.39
COMMON STOCK DIVIDENDS DECLARED PER SHARE OF COMMON STOCK	$ 0.22	$ 0.215	$ 0.15
WEIGHTED AVERAGE COMMON SHARES:
Basic	5,774,000	5,732,000	5,678,000
Diluted	5,906,000	5,854,000	5,797,000